These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. Int J Cancer; 2003 Oct 10; 106(6):896-904. PubMed ID: 12918067 [Abstract] [Full Text] [Related]
3. Effectiveness of preventive human papillomavirus vaccination. Lehtinen M, Paavonen J. Int J STD AIDS; 2003 Dec 10; 14(12):787-92. PubMed ID: 14678583 [Abstract] [Full Text] [Related]
4. [Prophylactic and therapeutic vaccine therapy in papillomavirus infections]. Vinatier D, Cosson M, Dufour P. Gynecol Obstet Fertil; 2000 May 10; 28(5):370-84. PubMed ID: 10893881 [Abstract] [Full Text] [Related]
6. Anti human papillomavirus vaccine: the checkmate to human papillomavirus? Moscarini M, Lukic A, Franco C. Eur J Gynaecol Oncol; 2004 May 10; 25(2):151-6. PubMed ID: 15032271 [Abstract] [Full Text] [Related]
7. [HPV vaccination--a possibility for prevention of cervical cancer]. Paavonen J. Duodecim; 2002 May 10; 118(21):2159-60. PubMed ID: 12486951 [No Abstract] [Full Text] [Related]
16. Prevention of carcinoma of cervix with human papillomavirus vaccine. Gavarasana S, Kalasapudi RS, Rao TD, Thirumala S. Indian J Cancer; 2000 Jun 04; 37(2-3):57-66. PubMed ID: 11876611 [Abstract] [Full Text] [Related]
19. Human papilloma virus vaccine for low and middle income countries: A step too soon? Jindal HA, Kaur A, Murugan S. Hum Vaccin Immunother; 2017 Nov 02; 13(11):2723-2725. PubMed ID: 28846491 [Abstract] [Full Text] [Related]